BioMarin Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:BM8 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Nov 24	Sell€330,180	C. Guyer	Individual	5,278	€62.56
06 Mar 24	Sell€157,980	Jean-Jacques Bienaime	Individual	2,000	€79.54
05 Mar 24	Sell€2,770,166	Henry Fuchs	Individual	35,341	€78.38
27 Feb 24	Sell€83,258	Jean-Jacques Bienaime	Individual	1,000	€83.26

Insider Trading Volume

Insider Buying: BM8 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BM8?
Owner Type	Number of Shares	Ownership Percentage
State or Government	176,635	0.0927%
Individual Insiders	1,481,977	0.778%
General Public	4,645,863	2.44%
Hedge Funds	9,753,293	5.12%
Institutions	174,525,248	91.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.41% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.9%	BlackRock, Inc.	22,623,503	€1.5b	-0.51%	0.02%
10.1%	The Vanguard Group, Inc.	19,278,654	€1.2b	1.5%	0.02%
9.9%	PRIMECAP Management Company	18,867,435	€1.2b	0.41%	0.89%
7.29%	Dodge & Cox	13,898,318	€891.6m	-0.23%	0.31%
5.51%	Capital Research and Management Company	10,494,955	€673.3m	8.28%	0.03%
5.12%	Viking Global Investors LP	9,753,293	€625.7m	38.1%	2.23%
4.63%	State Street Global Advisors, Inc.	8,823,114	€566.0m	-8.44%	0.02%
2.25%	Columbia Management Investment Advisers, LLC	4,281,482	€274.7m	-8.93%	0.06%
1.9%	Norges Bank Investment Management	3,619,503	€232.2m	0%	0.02%
1.84%	Elliott Management Corporation	3,500,338	€224.6m	0%	1.79%
1.71%	Geode Capital Management, LLC	3,260,050	€209.1m	1.9%	0.01%
1.26%	JP Morgan Asset Management	2,395,972	€153.7m	6.03%	0.02%
1.21%	BNY Asset Management	2,307,338	€148.0m	-0.77%	0.03%
1.07%	Avoro Capital Advisors LLC	2,038,015	€130.7m	-55.3%	1.89%
0.91%	UBS Asset Management AG	1,742,424	€111.8m	24.6%	0.01%
0.8%	Deutsche Asset & Wealth Management	1,533,072	€98.4m	-14.5%	0.03%
0.78%	Northern Trust Global Investments	1,484,358	€95.2m	-5.95%	0.01%
0.77%	Legal & General Investment Management Limited	1,471,049	€94.4m	-3.15%	0.02%
0.74%	Charles Schwab Investment Management, Inc.	1,401,628	€89.9m	4.14%	0.02%
0.7%	Dimensional Fund Advisors LP	1,339,721	€85.9m	29.5%	0.01%
0.65%	Rothschild & Cie Gestion	1,230,709	€79.0m	0%	1.44%
0.63%	Citadel Advisors LLC	1,204,397	€77.3m	116%	0.09%
0.61%	1832 Asset Management L.P.	1,164,391	€74.7m	4,920%	0.1%
0.58%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,096,300	€70.3m	11.4%	0.02%
0.57%	Palo Alto Investors LP	1,090,056	€69.9m	-3.55%	10.2%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/29 04:29
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioMarin Pharmaceutical Inc. is covered by 56 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Ishan Majumdar	Baptista Research
Huidong Wang	Barclays